booster – Page 57 – Communicable Diseases Research

Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups

Abbott Alinity SARS-CoV-2 스파이크 특이적 정량적 IgG 및 IgM 분석의 감염, 회복 및 백신 접종 그룹의 임상 평가

Article

Published on 2021-06-182022-09-11
Journal: Journal of Clinical Microbiology [Category] MERS, SARS, 진단, 치료법,

BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers

Article

Published on 2021-06-182022-10-28
Journal: Vaccines [Category] COVID-19,

Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa

남아프리카 공화국에서 HIV에 노출된 감염 및 비감염 유아를 위한 6가 소아 백신의 면역원성과 안전성

Article

Published on 2021-06-032024-08-18
Journal: Human vaccines & immunotherapeutics [Category] 백일해, 파상풍,

[키워드] booster hexavalent historical comparison HIV-exposed HIV-infected Primary series Vaccine

IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers

Research Article

Published on 2021-06-022022-10-30
Journal: mSphere [Category] COVID-19,

[키워드] antibody Antibody titer Antibody titers approved Blood booster calculated can be used caused Cell clinical clinical samples clinical specificity Clinical use clinical validation Concentration correlated country COVID-19 COVID-19 vaccines Critical death determinant development disease displaying dosing schedule elicit feasibility FIVE future infection gold standard high-throughput assay human serum Infection infections limit limit of detection measure monoclonal antibody Neutralizing antibodies neutralizing antibody Neutralizing antibody response Neutralizing antibody titer parameter performed plaque-reduction neutralization test plasma Precision Prevent protective immune response question required SARS-CoV-2 SARS-CoV-2 immunity SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 spike glycoprotein SARS-CoV-2-neutralizing antibodies SARS-CoV-2-neutralizing antibody sensitivity standard curve strong immune response surrogate virus titer turn utility vaccinated individual vaccinated individuals vaccination Vaccine Vaccine-induced immunity validation vesicular stomatitis virus virus virus assay widespread
[DOI] 10.1128/mSphere.00170-21 PMC 바로가기 [Article Type] Research Article

Encapsulated Food Products as a Strategy to Strengthen Immunity Against COVID-19

Nutrition

Published on 2021-05-212022-10-31
Journal: Frontiers in Nutrition [Category] COVID-19,

[키워드] Against Antimicrobials antioxidant antioxidants approved BAC benefit bioactive compounds Bioavailability boost booster component Compound coronavirus coronavirus disease country COVID-19 COVID-19 outbreak Curcumin develop encapsulated food facilitate fatty fatty acids food functional high stability highlight Human immune system immune system Immunity immunological immunological activity IMPROVE inhibit Interaction mechanisms Minerals Novel coronavirus offer outbreak Prevent preventive measure probiotic bacteria Probiotics product researchers SARS-CoV-2 Strategy sustained Treatment virus attack vitamins
[DOI] 10.3389/fnut.2021.673174 PMC 바로가기 [Article Type] Nutrition

Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution

다발성 골수종 및 골수증식성 악성종양 환자에 대한 항SARS-CoV-2 BNT162b2 백신의 5주 면역원성 및 활성 치료에 대한 안전성: 단일 기관의 예비 데이터

Clinical Trial

Published on 2021-05-172022-08-13
Journal: Journal of Hematology & Oncology [Category] SARS, 임상, 진단,

[키워드] anti-cancer treatment anti-CD38 anti-SARS-CoV-2 anti-SARS-CoV-2 IgG approved assumed basal BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine BNT162b2 vaccine booster Cancer chemiluminescent immunoassay chronic myeloid leukemias Cohort cohorts Committee Concentration Concordance Contagion Control Cutoff daratumumab demonstrated disease dose Endpoint evaluated Evidence family family members FDA first dose Gender geometric mean Geometric mean concentrations geometric mean ratio geometric mean ratios GMC GMCs hematological Hematological malignancy IgG IgG test immunogenic immunogenicity increasing age IRCCS Lazio less leukemia likelihood Linear model logarithm maintain Mann–Whitney test Mask Masks mRNA vaccine Multiple myeloma myeloproliferative malignancies myeloproliferative malignancy myeloproliferative neoplasms neutralization test Neutralizing of BNT162b2 Patient patients plaque Plaque reduction neutralization test positive Preliminary data primary endpoint Protective Quantitative reduce Responder responders response response rates Result risk robust S1/S2 Safety SARS-CoV-2 Serologically Seroprotection rate significantly social distancing Swab swabs Test titers titration Treatment vaccination Vaccination Status was done were excluded
[DOI] 10.1186/s13045-021-01090-6 PMC 바로가기 [Article Type] Clinical Trial

Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine

Research Article

Published on 2021-05-112022-10-31
Journal: Diabetes/metabolism research and reviews [Category] COVID-19, SARS,

[키워드] age antibody Antibody titre approach benefit blood sample BMI body composition booster Central obesity clinical collected COVID‐19 demographics determine elapsed enrolled Gender healthcare worker hypertension hypertensive immunogenicity independent Infection likelihood mRNA vaccine Multivariate analysis neutralizing antibody normotensive obesity parameter Pfizer/BioNTech Result SARS CoV‐2 SARS‐CoV‐2 separated serological response serum lipid Side effect smoker smoking subject titre titres vaccination Vaccine variable virus Waist circumference was performed were measured were recorded
[DOI] 10.1002/dmrr.3465 PMC 바로가기 [Article Type] Research Article

Kidney transplant dysfunction in a patient with COVID − 19 infection: role of concurrent Sars-Cov 2 nephropathy, chronic rejection and vitamin C-mediated hyperoxalosis: case report

Case Report

Published on 2021-03-152022-10-28
Journal: BMC Nephrology [Category] COVID-19,

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

BNT162b2 백신 유도 인간 혈청에 의한 SARS-CoV-2 계통 B.1.1.7 슈도바이러스 중화

Report

Published on 2021-03-122022-09-10
Journal: Science (New York, N.y.) [Category] Fulltext, SARS, 변종, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 affected age Amino acid amino acid change B.1.1.7 B.1.1.7 lineage BNT162b2 booster changes in coronavirus COVID-19 vaccine effective Effectiveness Efficacy faster genetic change group human sera immune immunized Lineage Lineage B.1.1.7 messenger mRNA vaccine mutations neutralization Neutralizing antibodies neutralizing antibody Neutralizing titer participant Perspective preserved PROTECT Protective Protein provide pseudovirus pseudoviruses raising reduced reference strain remained reported respiratory SARS-CoV-2 SARS-CoV-2 lineage SARS-CoV-2-S Science sera serum severe acute respiratory syndrome Coronavirus significant decrease Spike protein Spread Strains subject tested the spike protein the vaccine These data Transmissibility Trial United Kingdom Vaccine variant variant of SARS-CoV-2 VOC 202012/01 Wuhan
[DOI] 10.1126/science.abg6105 PMC 바로가기 [Article Type] Report

An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers

호주 의료 종사자에서 1차 또는 후속 백일해 부스터 백신 접종에 대한 항체 반응에 대한 관찰 연구

Article

Published on 2021-03-122024-08-18
Journal: Vaccine [Category] 백일해, 파상풍,

[키워드] Adults antibody waning booster Diphtheria IgG immune memory immunogenicity pertussis Tdap Tetanus vaccination Whooping cough
[DOI] 10.1016/j.vaccine.2021.01.041